https://orcid.org/0000-0003-0790-3096
References
- Butts A, Krysan DJ. 2012. Antifungal drug discovery: something old and something new. PLoS Pathog. 8(9):e1002870. doi: 10.1371/journal.ppat.1002870.
- de Andrade Monteiro C, Ribeiro Alves dos Santos J. 2020. Phytochemicals and their antifungal potential against pathogenic yeasts. In: Phytochemicals in human health edited by Rao V, Mans D and Rao L; p. 1–31. IntechOpen. London, UK. doi: 10.5772/intechopen.87302.
- Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, Burke MD. 2012. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A. 109(7):2234–2239. doi: 10.1073/pnas.1117280109.
- Jha A, Kumar A. 2019. Anticandidal agent for multiple targets: the next paradigm in the discovery of proficient therapeutics/overcoming drug resistance. Future Med Chem. 11(22):2955–2974. doi: 10.4155/fmc-2018-0479.
- Jin YS. 2019. Recent advances in natural antifungal flavonoids and their derivatives. Bioorg Med Chem Lett. 29(19):126589. doi: 10.1016/j.bmcl.2019.07.048.
- Lone SA, Khan S, Ahmad A. 2020. Inhibition of ergosterol synthesis in Candida albicans by novel eugenol tosylate congeners targeting sterol 14α-demethylase (CYP51) enzyme. Arch Microbiol. 202(4):711–726. doi: 10.1007/s00203-019-01781-2.
- Nazzaro F, Fratianni F, Coppola R, De Feo V. 2017. Essential oils and antifungal activity. Pharmaceuticals. 10(4):86. doi: 10.3390/ph10040086.
- Pan J, Hu C, Yu JH. 2018. Lipid biosynthesis as an antifungal target. J Fungi. 4(2):50. doi: 10.3390/jof4020050.
- Saeed A, Channar PA, Larik FA, Jabeen F, Muqadar U, Saeed S, Flörke U, Ismail H, Dilshad E, Mirza B. 2017. Design, synthesis, molecular docking studies of organotin-drug derivatives as multi-target agents against antibacterial, antifungal, α-amylase, α-glucosidase and butyrylcholinesterase. Inorg Chim Acta. 464:204–213. doi: 10.1016/j.ica.2017.05.036.